(IN BRIEF) Outokumpu has successfully completed its share repurchase program, acquiring a total of 157,620 treasury shares across multiple trading venues at an average price of EUR 4.46 per share. The program, announced on November 29, 2023, allowed for the repurchase of a maximum of 11 million shares and was authorized by the Annual General Meeting, with a total budget of up to EUR 50 million. After these transactions, Outokumpu now holds 24,516,272 treasury shares.
(PRESS RELEASE) HELSINKI, 16-Dec-2023 — /EuropaWire/ —
On December 14, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422):
Trading venue | Number of shares | Weighted average price / share, EUR* | Total cost, EUR* |
CEUX | 82,890 | 4.4611 | 369,776.90 |
XHEL | 74,264 | 4.4601 | 331,225.87 |
AQEU | 466 | 4.457 | 2,076.96 |
Total: | 157,620 | 4.46 | 703,079.73 |
* Rounded to two decimals
Outokumpu announced a share buyback program of a maximum of 11 million shares on November 29, 2023. The Board of Directors approved a share buyback program of up to EUR 50 million under the authorization of the Annual General Meeting. The program will end no later than on March 21, 2024.
After the disclosed transactions, Outokumpu holds 24,516,272 treasury shares.
Details of transactions are included as an appendix to this announcement.
Media Contacts:
Investors:
Linda Häkkilä
Head of Investor Relations
tel. +358 400 719 669
Media:
Päivi Allenius
VP – Communications & Brand
tel. +358 40 753 7374
Outokumpu media desk
+358 40 351 9840
SOURCE: Outokumpu Oyj
MORE ON OUTOKUMPU, ETC.:
(IN BRIEF) BASF solidifies its commitment to the WorldSkills movement by signing a multi-year global…
(IN BRIEF) Siemens AG and Hon Hai Technology Group (Foxconn) have inked a memorandum of…
(IN BRIEF) The highly anticipated Eras Tour by Taylor Swift is poised to inject a…
(IN BRIEF) The Future Circular Collider (FCC) study was prominently featured at the International Fair…
(IN BRIEF) ANDRITZ, a global technology group, has finalized the acquisition of NAF AB's business,…
(IN BRIEF) Researchers from the Universities of Tübingen and Göttingen have uncovered potential biosignatures of…